Drug recall · July 5, 2017
Minivelle recall
Why: Defective Delivery System: Out of specification for peel force from the release liner specification during stability testing at 18M 25C/60%RH.
Class III: unlikely to cause harm, but breaks the rules (for example a labeling error).
The recall
- Product
Minivelle (estradiol Transdermal System) 0.1 mg per day, pack of 8 systems per carton, Rx only, Dist. by: Noven Therapeutics, LLC. Miami, Florida 33186. NDC: 68968-6610-8
- Lots / codes
Lot #:: 78618, Exp. 05/2017
- Quantity
- 14434 cartons
- Company
- Noven Pharmaceuticals, Inc., Miami, FL
- Distribution
- Nationwide within US
- Initiated
- April 27, 2017 · Voluntary: Firm initiated
- Classified
- June 23, 2017
- Reported
- July 5, 2017
- Ended
- March 11, 2019
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Minivelle
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.